Key result
Cardiac-specific overexpression of AK1 in mice increased AK1 activity by 31% but led to unexpected increases in left ventricular weight and altered basal metabolism, without reducing in vivo infarct size following ischaemia/reperfusion.
Why the study?
It was hypothesised that increased adenylate kinase 1 activity would have negligible effects at rest but protect against ischaemia/reperfusion injury.
Does genetic overexpression of Adenylate kinase 1 protect against ischaemia/reperfusion injury and alter basal metabolism in the murine heart?
Does genetic overexpression of Adenylate kinase 1 protect against ischaemia/reperfusion injury and alter basal metabolism in the murine heart?
Effect estimate: 31% higher
p-value: p=0.009
Modest elevation of AK1 improves functional recovery post-ischaemia/reperfusion but unexpectedly alters basal LV weight, function, and metabolism, indicating a nuanced role in resting myocardial energy homeostasis.
AK1 overexpression fails to limit infarct size in mice despite higher activity; leaves open its nuanced effects on basal myocardial energetics.
Aims Adenylate kinase 1 (AK1) catalyses the reaction 2ADP ↔ ATP + AMP, extracting extra energy under metabolic stress and promoting energetic homeostasis. We hypothesised that increased AK1 activity would have negligible effects at rest, but protect against ischaemia/reperfusion (I/R) injury. Methods and Results Cardiac-specific AK1 overexpressing mice (AK1-OE) had 31% higher AK1 activity ( P = 0.009), with unchanged total creatine kinase and citrate synthase activities. Male AK1-OE exhibited mild in vivo dysfunction at baseline with lower LV pressure, impaired relaxation, and contractile reserve. LV weight was 19% higher in AK1-OE males due to higher tissue water content in the absence of hypertrophy or fibrosis. AK1-OE hearts had significantly raised creatine, unaltered total adenine nucleotides, and 20% higher AMP levels ( P = 0.05), but AMP-activated protein kinase was not activated ( P = 0.85). 1 H-NMR revealed significant differences in LV metabolite levels compared to wild-type, with aspartate, tyrosine, sphingomyelin, cholesterol all elevated, whereas taurine and triglycerides were significantly lower. Ex vivo global no-flow I/R, caused four-of-seven AK1-OE hearts to develop terminal arrhythmia (cf. zero WT), yet surviving AK1-OE hearts had improved functional recovery. However, AK1-OE did not influence infarct size in vivo and arrhythmias were only observed ex vivo , probably as an artefact of adenine nucleotide loss during cannulation. Conclusion Modest elevation of AK1 may improve functional recovery following I/R, but has unexpected impact on LV weight, function and metabolite levels under basal resting conditions, suggesting a more nuanced role for AK1 underpinning myocardial energy homeostasis and not just as a response to stress.
No takes yet. Share an insight, caveat, or question.
Zervou et al. (2021) studied Myocardial energy homeostasis and ischaemia/reperfusion injury. Cardiac-specific AK1 overexpression vs. Wild-type littermates was evaluated on AK1 activity (31% higher, p=0.009). Cardiac-specific overexpression of AK1 in mice increased AK1 activity by 31% but led to unexpected increases in left ventricular weight and altered basal metabolism, without reducing in vivo infarct size following ischaemia/reperfusion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: